Health

I-Mab Receives Top Rankings in Five Categories by Institutional Investor

GAITHERSBURG, Md. and SHANGHAI, June 23, 2022 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that it was ranked among the top companies i...

2022-06-23 20:00 1524

Short Videos of Traditional Chinese Medicine Culture Go Viral on YouTube

BEIJING, June 22, 2022 /PRNewswire/ -- A news report by haiwainet.cn: Traditional Chinese Medicine (TCM) has a history of more than 5,000 years that nurtures the Chinese view of life and health, man and nature, and man and the universe, it has since become an inseparable and important part of Chi...

2022-06-23 11:14 1663

Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials

SHANGHAI, June 22, 2022 /PRNewswire/ -- Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion of an $80 million Series B Financing. The funds will be used to commercialize its Viridimin™ brand of anim...

2022-06-23 09:00 1885

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

HAIKOU, China, June 22, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that onJune 15, 2022, the Company received a letter from NYSE American LLC ("NYSE American" or the "Exchange"...

2022-06-23 05:00 2534

Scientists take the first step to master an all-powerful cell type in the beginning of life

Sheng Ding and his team at Tsinghua University School of Pharmaceutical Sciences publish innovative work in Nature BEIJING, June 21, 2022 /PRNewswire/ -- From cloning to regeneration, how to find alternative paths to create or rejuvenate life has been one of the big questions for biologists. It ...

2022-06-21 23:10 2254

Prof. Cho, head of the lung cancer center at Yonsei Cancer Hospital, "J INTS BIO's new oral administration 4th generation EGFR TKI 'JIN-A02' expected to be a game changer"

SEOUL, South Korea, June 21, 2022 /PRNewswire/ -- Prof. Cho Byoung-chul at Yonsei University College of Medicine (Director, Lung Cancer Center, Yonsei Cancer Hospital) is one of the most influential researchers in the lung cancer field and is involved in the development of innovative new drugs gl...

2022-06-21 17:00 1443

Nippon Express Launches New Transport Service Using Environment-friendly Isothermal Packaging

TOKYO, June 21, 2022 /PRNewswire/ -- -First Japanese Logistics Company to Collaborate with EMBALL'ISO, Experienced in Vaccine Transport- Nippon Express Co., Ltd., a group company of Nippon Express Holdings, Inc., has become the first Japanese logistics company to collaborate with EMBALL'ISO, a...

2022-06-21 14:00 1037

Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform

BEIJING, June 20, 2022 /PRNewswire/ -- Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) technology-based new vaccines and therapies, announced the completion of aUS$42 million Series A financing round. The round was co-led by a ...

2022-06-21 08:00 1595

Acepodia Announces FDA Clearance of IND Application for ACE1831, an Anti-CD20 Armed Allogeneic gamma delta T-cell Therapy Candidate to Treat Patients with non-Hodgkin's Lymphoma

ACE1831 is a potential antibody‑armed allogeneic gamma delta T cell therapy developed using Acepodia's unique antibody-cell conjugation (ACC) technology as an optimized T cell engager platform to treat patients with non-Hodgkin's lymphoma ALAMEDA, Calif. and TAIPEI, Taiwan, June 20, 2022 /PRNews...

2022-06-20 20:00 1906

2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines

TAIPEI, Taiwan, June 18, 2022 /PRNewswire/ -- After the 2014 and 2016 winners for the Tang Prize in Biopharmaceutical Sciences were crowned the Nobel Prize in 2018 and 2020 respectively, this category has continued to garner much attention worldwide. After much waiting, names of the latest winner...

2022-06-19 10:30 3136

2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines

TAIPEI, Taiwan , June 18, 2022 /PRNewswire/ -- After the 2014 and 2016 winners for the Tang Prize in Biopharmaceutical Sciences were crowned the Nobel Prize in 2018 and 2020 respectively, this category has continued to garner much attention worldwide. After much waiting, names of the latest winne...

2022-06-19 10:30 3048

Memorial MRI & Diagnostic Installs United Imaging's Pioneering 75 cm, Ultra-Wide-Bore uMR OMEGA™

HOUSTON, June 17, 2022 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, and Memorial MRI & Diagnostic, a leader in diagnostic and imaging services inTexas, celebrated the installation of new technology for its patients inKaty, T...

2022-06-17 21:00 4473

US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER

SYDNEY, June 17, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to Kazia's paxalisib for the treatmen...

2022-06-17 20:00 3770

Lunit Files Registration Statement for Initial Public Offering

* First Korean healthcare company to obtain "AA-AA" ratings in technology assessment for its FDA-cleared and CE-marked solutions * To accelerate listing on the KOSDAQ market within July SEOUL, South Korea, June 16, 2022 /PRNewswire/ -- Lunit, a leading provider of AI solutions for cancer, tod...

2022-06-16 21:00 2465

Bon Natural Life Limited Introduces New Powder Drink For Anti-H. Pylori and Digestive Health

XI'AN, China, June 16, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has launched a new cruciferous vegetable based probiotic ...

2022-06-16 20:30 3996

111, Inc. Announces First Quarter 2022 Unaudited Financial Results

SHANGHAI, June 16, 2022 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the first quart...

2022-06-16 15:58 4141

WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies

PHILADELPHIA and ST. LOUIS, MO and SAN DIEGO, June 15, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO), and Wugen Inc., a clinical-stage biotechnology company based inSt. Louis and San Diego, today announced a ...

2022-06-16 08:00 1883

I-Mab Partner MorphoSys Announces New License Agreements for Felzartamab and TJ210

SHANGHAI and GAITHERSBURG, Md., June 15, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced two assets the Company has licensed from partner Morpho...

2022-06-15 22:37 2548

Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting

SHANGHAI, June 15, 2022 /PRNewswire/ -- Burning Rock (NASDAQ:BNR) presented the final results from the multi-center case-control THUNDER study (THe UNintrusive Detection of EaRly-stage cancer, NCT04820868) in a poster entitled "Unintrusive multi-cancer detection by circulating cell-free DNA methy...

2022-06-15 20:01 2049

Waterdrop Inc. Announces First Quarter 2022 Unaudited Financial Results

BEIJING, June 15, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the first quarter ended March 31, ...

2022-06-15 14:50 4055
1 ... 140141142143144145146 ... 273